v3 Template
S

Shattuck Labs Inc.

Biotechnology / Healthcare Austin, Texas and Durham, North Carolina ~540 employees
Founded
--
Employees (Est.)
~540
27 leaders known
Total Funding
$153.0M
Funding Rounds
2
Last Funding
2025-08-05

About Shattuck Labs Inc.

Shattuck Labs is a biotechnology company focused on developing novel biologic medicines through protein engineering. Their mission is to deliver transformative drugs that improve patients' lives, particularly in oncology and autoimmune/inflammatory diseases, by leveraging a deep understanding of TNF receptor biology.

Products & Services

SL-325:A potentially first-in-class monoclonal antibody antagonist of Death Receptor 3 (DR3), targeting the TL1A/DR3 pathway for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory autoimmune diseases.

Specialties

TNF Receptor Modulators Protein Engineering Autoimmune and Inflammatory Disease Treatments Oncology Therapeutics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement
A: 103000000
MR: -
FA: Up to approximately $103 million
FAN: 103000000
D: 2025-08-05
FD: 2025-08-05
7 investors
2 RT: Public Offering and Private Placement
T: -
FT: Public Offering and Private Placement
A: 50000000
MR: -
FA: approximately $50 million
FAN: 50000000
D: 2023-12-21
FD: 2023-12-21
-
Private Placement Latest
2025-08-05
$103.0M
7 investors (Pro only)
Public Offering and Private Placement 2023-12-21
$50.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

H

Helen Boudreau

Financial Expert and Committee Chair

T

Tyler Brous

Managing Director and Portfolio Manager

C

Carrie Brownstein

Former Chief Medical Officer of Zentalis Pharmaceuticals

N

Neil Gibson

Chief Scientific Officer, Biologics

G

George Golumbeski

Chairman of the Board and Former Executive Vice President of Business Development for Celgene

C

Clay Siegall

President, Chief Executive Officer and Chairman of the Board of Immunome, Inc.

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Shattuck Labs Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~540 employees (est.)
Locations
Austin, Texas and Durham, North Carolina
Austin, TX and Durham, NC

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro